The 17 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 75.00, with a high estimate of 90.00 and a low estimate of 62.00. The median estimate represents a +12.29% increase from the last price of 66.79.
The current consensus among 19 polled investment analysts is to Buy stock in Bristol-Myers Squibb Co. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.91
Reporting Date Jul 28
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.